Effects of Elobixibat, an Inhibitor of Ileal Bile Acid Transporter, on Glucose and Lipid Metabolism: A Single-arm Pilot Study in Patients with T2DM-Reference-Cited by-同舟云学术

Effects of Elobixibat, an Inhibitor of Ileal Bile Acid Transporter, on Glucose and Lipid Metabolism: A Single-arm Pilot Study in Patients with T2DM

Published:2022-10 Issue:10 Volume:44 Page:1418-1426
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Yoshinobu Satoko,Hasuzawa Nao^ORCID,Nagayama Ayako,Iwata Shimpei,Yasuda Junichi,Tokubuchi Rie,Kabashima Masaharu,Gobaru Mizuki,Hara Kento,Murotani Kenta,Moriyama Yoshinori,Ashida Kenji,Nomura Masatoshi

Funder

Kurume University

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Bile acid metabolism and signaling;Chiang;Compr Physiol,2013

2. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism;Lu;J Biol Chem,2001

3. Bile acids and FXR: novel targets for liver diseases;Stofan;Front Med (Lausanne),2020

4. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c;Watanabe;J Clin Invest,2004

5. Intestinal absorption of bile acids in health and disease;Ticho;Compr Physiol,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of hepatic bile salt uptake by Bulevirtide reduces atherosclerosis in Oatp1a1 Ldlr mice;Journal of Lipid Research;2024-08

2. Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases;Medical Review;2024-06-04

3. Development and Validation of a Risk Nomogram Model for Predicting Constipation in Patients with Type 2 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity;2023-04